Bullous Pemphigoid (BP)

DBCOND0074370Immune System DiseasesSkin and Subcutaneous Tissue Diseases

Bullous Pemphigoid (BP) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Pemphigoid, Bullous · Bullous Pemphigoid · bullous pemphigus
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0016111ICD-10L12SNOMED CT156356009MedDRA10006567UMLSC0030805

What you can answer from here — as of October 21, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
51Clinical trialsPhase, status and sponsor resolved per trial
Sign in
14Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Bullous Pemphigoid (BP) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In